Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / First Light Asset Management, LLC
Form 13F · Q2 2026

First Light Asset Management, LLC

CIK 1600004Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.6B
Reported book value
31
Positions
12
Quarters on record
Top 50
Positions

First Light Asset Management, LLC — holdings

Top 31 positions of 31, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1NEO Neogenomics Inc12.3M+26.2%$179M10.9%
2SIBN Si Bone Inc8.1M+51.8%$133M8.1%
3AXGN Axogen Inc2.7M−31.3%$127M7.7%
4APOGEE THERAPEUTICS INC Apogee Therapeutics Inc930,289+61.3%$123M7.5%
5PVLA Palvella Therapeutics Inc Ne771,901−21.3%$118M7.2%
6TWST Twist Bioscience Corp727,933−17.2%$75M4.6%
7ELVN Enliven Therapeutics Inc1.4M+574.1%$69M4.2%
8GH Guardant Health Inc441,586+57.5%$66M4.0%
9MASS 908 Devices Inc6.3M+3.5%$55M3.3%
10AMLX Amylyx Pharmaceuticals Inc3.0M−5.2%$54M3.3%
11WGS Genedx Holdings Corp783,923+222.7%$54M3.3%
12SIMULATIONS PLUS INC Simulations Plus Inc2.8M+6.1%$51M3.1%
13TNDM Tandem Diabetes Care Inc3.4M+157.4%$51M3.1%
14CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In1.4M+24.9%$51M3.1%
15NPCE Neuropace Inc2.9M+16.3%$45M2.8%
16EWTX Edgewise Therapeutics Inc1.1M+9.3%$44M2.7%
17ANAB Anaptysbio Inc582,004+2.9%$39M2.4%
18TRVI Trevi Therapeutics Inc2.1M—$39M2.4%
19SEPN Septerna Inc963,260+31.4%$32M2.0%
20TLSI Trisalus Life Sciences Inc6.6M+29.3%$30M1.8%
21TECX Tectonic Therapeutic Inc800,726+23.6%$28M1.7%
22HCAT Health Catalyst Inc12.8M−0.5%$25M1.5%
23BFLY Butterfly Network Inc2.6M−0.7%$22M1.4%
24ESTA Establishment Labs Hldgs Inc246,577−19.9%$21M1.3%
25PCVX Vaxcyte Inc345,157+143.4%$20M1.2%
26IRTC Irhythm Holdings Inc167,092−0.6%$20M1.2%
27OMCL Omnicell Com452,324−7.7%$19M1.1%
28ATRC Atricure Inc567,838−22.2%$16M1.0%
29KRMD Koru Medical Systems Inc3.4M−10.1%$14M0.9%
30TACTILE SYS TECHNOLOGY INC Tactile Sys Technology Inc462,562—$14M0.8%
31RYTM Rhythm Pharmaceuticals Inc85,765−1.6%$10M0.6%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.